FMS: מחיר למכירות Fresenius Medical Care Corp

The normalized P/S of Fresenius Medical Care (FMS) illustrates the valuation dynamics of a company striving for global leadership in dialysis through mergers and AI technologies. The current value of 0.50 shows the real-time magnitude of the multiple. The business generates revenue from equipment sales and clinics for kidney patients, while stable demand for hemodialysis ensures a steady cash flow and operational resilience.

Fresenius Medical Care maintains a stable revenue stream driven by its status as a global leader in dialysis and patient trust, which serves as the foundation for calculating the P/S ratio. This metric compares market capitalization to annual revenue, allowing this price-to-sales chart to identify unjustified growth in asset valuation amid stagnating sales, signaling a risk of a deep correction.